- Home
- ICLR vs CPT Comparison
ICLR vs CPT Comparison
Compare ICLR & CPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- CPT
- Stock Information
- Founded
- ICLR 1990
- CPT 1993
- Country
- ICLR Ireland
- CPT United States
- Employees
- ICLR N/A
- CPT N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- CPT Real Estate Investment Trusts
- Sector
- ICLR Health Care
- CPT Real Estate
- Exchange
- ICLR Nasdaq
- CPT Nasdaq
- Market Cap
- ICLR 13.7B
- CPT 11.9B
- IPO Year
- ICLR 1998
- CPT 1993
- Fundamental
- Price
- ICLR $173.13
- CPT $107.09
- Analyst Decision
- ICLR Buy
- CPT Buy
- Analyst Count
- ICLR 15
- CPT 16
- Target Price
- ICLR $209.93
- CPT $124.73
- AVG Volume (30 Days)
- ICLR 1.1M
- CPT 790.5K
- Earning Date
- ICLR 10-22-2025
- CPT 10-30-2025
- Dividend Yield
- ICLR N/A
- CPT 3.91%
- EPS Growth
- ICLR 13.11
- CPT N/A
- EPS
- ICLR 9.73
- CPT 1.43
- Revenue
- ICLR $8,089,820,000.00
- CPT $1,570,124,000.00
- Revenue This Year
- ICLR N/A
- CPT $2.74
- Revenue Next Year
- ICLR $1.73
- CPT $2.75
- P/E Ratio
- ICLR $17.51
- CPT $75.05
- Revenue Growth
- ICLR N/A
- CPT 0.75
- 52 Week Low
- ICLR $125.10
- CPT $102.35
- 52 Week High
- ICLR $310.54
- CPT $127.69
- Technical
- Relative Strength Index (RSI)
- ICLR 51.75
- CPT 51.14
- Support Level
- ICLR N/A
- CPT N/A
- Resistance Level
- ICLR $176.07
- CPT $112.26
- Average True Range (ATR)
- ICLR 6.17
- CPT 1.77
- MACD
- ICLR -7.19
- CPT -4.12
- Stochastic Oscillator
- ICLR 94.78
- CPT 95.38
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.